Navigation Links
Gene connected to Multi-System disorder discovered

A complex and rare disorder that affects many systems of the body, called oculodentodigital dysplasia, has been found to be the result of faulty cell communication. This syndrome is said to affect various body structures including the eyes, face, teeth and fingers and can also cause hearing loss, heart trouble// and neurological problems. A Hopkins-led research team, which studied the genetic samples and medical histories from 17 families with the syndrome, has discovered that changes in a gene called connexin 43 are to blame for the disorder.

Researchers have expressed astonishment at the delay in linking a connexin gene to the disorder which affects so many body systems as connexin 43 and related genes are present in many tissues during development. However, they also add that until now problems with connexins had only been tied to simpler manifestations.

Connexins are a family of roughly 20 genes, best known for creating connections between cells, bridging space called a "gap junction". When connexins on one cell interact with connexins on a neighboring cell, the result is a direct line of communication.

The study involved 17 families in the United States, the Netherlands, Norway and Turkey, and 100 additional people. Scientists suspected the involvement of connexin 43 in the disorder since the gene is turned on in fetal development in a pattern that reflects the problems seen in oculodentodigital dysplasia. They therefore determined the sequence of its building blocks in affected and unaffected members of the 17 families. The researchers reported that only people with the disorder had changes in connexin 43. The researchers also reported that though a different change, or mutation, in the gene was found in each of the 17 families,all changes altered the instructions to make the connexin 43 protein. However, the exact effect of the changes on the protein are yet to be studied.

Scientists suggest that problems with conne
'"/>




Page: 1 2

Related medicine news :

1. Sex exploitation connected to Schizophrenia
2. Diet, Sunlight connected to Breast Cancer Risk
3. Mutation connected to Osteoporosis
4. Tobacco and alcohol connected to larger health problems
5. Toxin connected to Flesh-eating Pneumonia in Kids
6. Leptin connected to obesity blood clots
7. Ulcer Surgery connected to danger of Pancreatic Cancer
8. Control of anger disorder connected to Brain Dysfunction
9. Altitude sickness connected to genes
10. Tremors connected to Body Mass Index
11. Hyperflexible joints connected to chronic fatigue
Post Your Comments:
(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... The Drug Information Association ...ill host the Critical Path Initiative (CPI) on the...16; Bethesda, MD) and the Critical Path Transporte... Horsham, PA (PRWEB) July 25...mation Association (DIA)] and the Food and Drug Ad...
(Date:7/24/2008)...TON-SALEM, N.C. Researchers at Wake Forest Unive...-standing clinical belief that the hepatitis C vir...restore itself after HIV patients are treated with..., Hepatitis C (HCV) infection is more serious in...e, according to the Centers for Disease Control. I...
(Date:7/24/2008)...UTH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 ... to report its 2008 second quarter and,year-to-dat...second quarter,and year-to-date financial results ...ding hours., The company will host a conference c...m. Eastern Time) on Tuesday, July 29, 2008. ev3,ma...
Breaking Medicine News(10 mins):Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2
...s usually indicated by itchy flaky scalp to give ...say you can treat dandruff by using a medicated sh...brands from time to time, as individual products m...air with the shampoo every day or so, and make sur...
...ling over visions of adult stem cells as a less ho...lternative to embryonic stem cells, whose ability ...between those who think such research destroys a l...l. The new findings challenge the notion adult ste...
...potato may become a reality some day, according to...that// muscle cells use to build strength and endu...may be possible to develop a pill that pumps up mu...said Dr. R. Sanders Williams, dean of the Duke Uni...
...ound in fish oil halves the risk of sudden death i...und that eating oily fish such as tuna and salmon ...ed by a particular type of irregular heartbeat. Th...han dietary fish oil, could be a therapy without s...
Other Medicine News:Health News:A question on study of Adult Stem Cell 2Health News:A question on study of Adult Stem Cell 3
(Date:7/22/2008)...s Including Lantus(R) and Apidra(R) Resulted in Si... 2 Diabetes, Whatever the Algorithm ...22 /- Results from the "Adjust to,Tar...orithm to Carbohydrate,Counting for Adjustment of ...in the American Diabetes Association,s (ADA) medic...
(Date:7/22/2008)... treatment with chemotherapy and pegylated enzyme ...ed to chemotherapy alone - - Pegy... /- Halozyme Therapeutics,... developing and,commercializing products targeting...sentation of positive pre-clinical animal efficacy...
(Date:7/22/2008)...IPOLIS, France, July 22 /- ...t has successfully completed the,enrollment of 417...rtension,in two clinical pharmacology studies in t...d timelines. These trials are designed to assess t...rison to ibuprofen and,naproxen, using the Ambulat...
(Date:7/21/2008)...ing to focus on use of Zevalin as consolidation th...reated patients with follicular ...re-FirstCall/ -- Cell Therapeutics, Inc.,(CTI) (Na...ny has scheduled,a meeting with the U.S. Food and ...the possibility of filing a supplemental Biologics...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4American Chemical Societys Weekly Presspac Sept 5 2007 853 1American Chemical Societys Weekly Presspac Sept 5 2007 853 2American Chemical Societys Weekly Presspac Sept 5 2007 853 3American Chemical Societys Weekly Presspac Sept 5 2007 853 4American Chemical Societys Weekly Presspac Sept 5 2007 853 5American Chemical Societys Weekly Presspac Sept 5 2007 853 6American Chemical Societys Weekly Presspac Sept 5 2007 853 7American Chemical Societys Weekly Presspac Sept 5 2007 853 8American Chemical Societys Weekly Presspac Sept 5 2007 853 9Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 1Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 2Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 1Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 2Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 1Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 2
...Closure of Multi-Center Trial in 4 Weeks Reinforce...s in Myeloma-, NORTH HOLLYWOOD, Calif., May 15, 20...ation (IMF) - supporting research and,providing ed...,families, researchers and physicians - today sai...enter myeloma trial using,REVLIMID(R) has demonstr...
... Poster Presented at Society for Investigative Der.../ -- AGI Dermatics,recently announced new comparat...cells have the ability to recognize, transport and...nst oxidative,damage, and importantly, that (EGT) ...than idebenone, scavenging reactive oxygen,species...
Other Medicine Technology:The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 2The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 3AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
... into the body more easily than any comparable sco...ching the lower pole calyces. Its smooth, lubricio...on of both scope and instruments. And its patented...us tip, and active secondary deflection deliver co...
...Ureteroscope permits direct visualization and acce... little or no dilation.,A tight bend radius and ...renal access, including the lower pole calyces. Du...reter and the renal pelvis. The 6.75 beveled tip f...
Smooth, contoured standard obturator provides less traumatic insertion through the urethra and into the bladder.
Electrohydraulic Lithotripsy Probe for AEH-4
Medicine Products: